Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Posterolateral Spinal Fusion — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-06-26
Ad — after-intro

Quick Facts

Procedure Type
Open Spinal Surgical Fusion
Specialty
Neurosurgery / Orthopaedic Spine Surgery
Anaesthesia
General anaesthesia
Hospital Stay
3–7 days
Recovery Time
3–6 months for fusion; full activity by 6–12 months
Fusion Success Rate
85–95% with instrumentation and autograft
Last Reviewed
2026-06-26
Reviewer
MyMedicPlus Medical Review Board

Overview

Posterolateral spinal fusion (PLF) is a surgical procedure in which two or more adjacent vertebrae are permanently fused together using bone graft material placed along the posterolateral gutters — the spaces between the transverse processes and facet joints at the back and sides of the spine. Pedicle screws and connecting rods (spinal instrumentation) are typically placed alongside the graft to provide immediate stabilization while the bone fusion matures.

PLF is one of the most commonly performed spinal fusion techniques and can be performed at any level of the spine, though it is most frequently used in the lumbar and lumbosacral regions. The surgical approach is posterior (through the back), and the operation targets the posterolateral elements of the spine rather than the intervertebral disc space — distinguishing it from interbody fusion techniques such as PLIF or TLIF.

The goal of posterolateral fusion is to eliminate painful or unstable motion at a diseased spinal segment, decompress neural structures where necessary, and correct spinal deformity. By creating a solid bony bridge across the affected vertebrae, the procedure halts further deterioration and provides lasting structural support. Over 500,000 lumbar fusion procedures are performed annually in the United States alone, making spine fusion one of the most studied orthopaedic operations in the world.

Conditions Treated

Posterolateral spinal fusion is indicated for a range of spinal disorders characterized by instability, deformity, or degenerative disease:

  • Degenerative disc disease (DDD): Progressive loss of intervertebral disc height and integrity causing axial back pain, loss of spinal alignment, and segmental instability. PLF eliminates motion at the painful segment.
  • Spondylolisthesis: Forward slippage of one vertebra over another, commonly at L4–L5 or L5–S1. Grades II–IV often require surgical stabilization and fusion to prevent neurological compromise.
  • Scoliosis: Abnormal lateral curvature of the spine. PLF is the gold-standard fusion technique for adolescent idiopathic scoliosis correction with posterior instrumentation and for adult degenerative scoliosis.
  • Spinal stenosis with instability: Narrowing of the spinal canal causing nerve compression; when decompression (laminectomy) would create additional instability, concurrent PLF is performed.
  • Isthmic spondylolysis: Stress fracture of the pars interarticularis, most common at L5, causing vertebral instability in young athletes and adults.
  • Revision surgery: Failed prior spinal surgery (adjacent segment disease, pseudarthrosis, implant failure) may require extension of fusion or revision PLF.
  • Spinal tumours and trauma: Selected cases where vertebral body integrity is preserved but posterior column stabilization is needed.

Who Is Eligible

Candidates for posterolateral spinal fusion are identified through a structured clinical and imaging assessment:

  • Failed conservative management: Patients who have not responded to at least 6 months of evidence-based non-surgical treatment — physiotherapy, NSAIDs, epidural steroid injections, and activity modification — for degenerative conditions. Emergency indications (progressive neurological deficit, cauda equina syndrome, spinal instability from trauma) bypass this requirement.
  • Radiological confirmation: MRI, CT, and weight-bearing X-rays confirming pathology at the level(s) to be fused, with imaging correlating to the clinical presentation.
  • Neurological stability or worsening: Patients with stable or declining neurological function from nerve compression who are not improving with conservative management.
  • General fitness for surgery: Adequate cardiorespiratory reserve, well-controlled comorbidities, and non-smoking status (or cessation). Smoking significantly impairs bone fusion — rates of pseudarthrosis are 2–3 times higher in active smokers.
  • Age considerations: PLF is performed across a wide age range. In adolescents with scoliosis it is the standard of care for curves above 45–50°. In elderly patients, surgical risk assessment and bone density (DEXA scan) are essential.

Contraindications include active spinal infection, severe osteoporosis without augmentation planning, and patients with unrealistic surgical expectations.

Treatment Options

Several fusion approaches and graft options exist; selection depends on pathology, patient factors, and surgeon expertise:

Posterolateral Fusion (PLF) — Standard Technique

A midline posterior incision exposes the posterior spine. After decompression (if required), decortication of the transverse processes and facet joints creates a vascular bed for bone graft adherence. Pedicle screws are inserted bilaterally, connected by titanium rods, and bone graft is packed into the posterolateral gutters. Closure is performed in layers with subfascial drain placement.

Combined PLF + Interbody Fusion

Posterolateral fusion is frequently combined with interbody cage placement (PLIF — posterior lumbar interbody fusion, or TLIF — transforaminal lumbar interbody fusion) for multi-column stability, restoration of disc height, and improved fusion rates. This combined approach is preferred for spondylolisthesis and multi-level DDD.

Bone Graft Options

  • Autograft (iliac crest bone graft — ICBG): Gold standard for biologic potential. Harvested from the patient's own posterior iliac crest, providing osteogenic cells, osteoinductive growth factors, and osteoconductive scaffold. Donor site pain is the primary limitation.
  • Allograft: Processed cadaveric bone; avoids donor site morbidity but has lower osteogenic potential. Frequently combined with autograft or BMP.
  • Bone morphogenetic protein (BMP-2, rhBMP-2): Recombinant growth factor (INFUSE Bone Graft) applied to a collagen sponge carrier. FDA-approved for single-level ALIF; used off-label in PLF. Enhances fusion rates but carries risks of heterotopic ossification and seroma formation.
  • Synthetic bone substitutes: Calcium phosphate ceramics, tricalcium phosphate, and demineralized bone matrix (DBM) serve as adjuncts or extenders to autograft.

Minimally Invasive Variants

Minimally invasive posterolateral fusion using percutaneous pedicle screw systems and tubular retractors reduces muscle trauma, blood loss, and recovery time in carefully selected patients. Fusion biology is equivalent to open approaches.

Benefits

  • High fusion success rates: With pedicle screw instrumentation and autograft, fusion rates reach 85–95% at 2 years. Adding interbody cage further improves rates to 90–98%.
  • Durable pain relief: Studies report 60–80% of patients achieve clinically meaningful reduction in back and leg pain following successful fusion for spondylolisthesis and DDD.
  • Spinal deformity correction: PLF with posterior rod instrumentation achieves Cobb angle correction of 60–70% in adolescent idiopathic scoliosis, with durable long-term maintenance.
  • Prevention of neurological deterioration: Stabilizing unstable segments protects nerve roots and the spinal cord from progressive damage.
  • Functional restoration: Improved walking capacity, ability to return to work, and restoration of activities of daily living reported in the majority of appropriately selected patients.
  • Well-established technique: Decades of outcomes data, published guidelines, and surgical training programmes make PLF one of the most evidence-supported spinal procedures available.

Risks and Complications

Posterolateral spinal fusion carries surgical risks that must be weighed against the severity of the spinal condition:

  • Pseudarthrosis (failed fusion): 5–15% of single-level fusions, higher in multi-level cases, smokers, and osteoporotic bone. May require revision surgery.
  • Neurological injury: Nerve root injury from retraction, pedicle screw malposition, or epidural haematoma can cause radiculopathy, weakness, or bladder/bowel dysfunction. Risk is less than 1% with intraoperative neuromonitoring.
  • Infection: Surgical site infection in 1–4% of cases. Deep infections involving hardware may require implant removal and prolonged antibiotic therapy.
  • Adjacent segment disease: Accelerated degeneration at spinal levels adjacent to the fusion occurs in approximately 25% of patients at 10 years, sometimes requiring further surgery.
  • Donor site pain (ICBG): Persistent iliac crest pain in 15–30% of patients at 1 year, though typically resolves by 2 years.
  • Hardware failure: Screw loosening or rod fracture, particularly in osteoporotic bone. Usually detected on surveillance imaging before causing clinical problems.
  • Blood loss: Multi-level fusion carries risk of significant blood loss; autologous blood banking or intraoperative cell salvage is recommended.
  • Pulmonary embolism / DVT: Risk minimized with pharmacological thromboprophylaxis and early mobilization.

Follow-Up and Recovery

Recovery from posterolateral spinal fusion follows a structured timeline:

  • Hospital stay (3–7 days): Pain management with multimodal analgesia, early mobilization with physiotherapy from day 1–2, drain removal, and wound care.
  • Weeks 1–6: Restricted activity; brace wear as prescribed (usually lumbar support orthosis for 6–12 weeks). Wound healing, staple/suture removal at 2 weeks. Driving restriction typically 4–6 weeks.
  • Weeks 6–12: Progressive physiotherapy including core stabilization, walking programme, and gentle range-of-motion exercises. Return to sedentary work possible for many patients at 6–8 weeks.
  • 3–6 months: CT scan at 3–6 months to assess fusion progress. Physiotherapy advances to strengthening. Manual work return typically at 3–6 months depending on fusion maturity.
  • 6–12 months: Bony fusion typically confirmed radiographically. Return to full activity including sports for appropriate patients. Annual spine review for 2–5 years to monitor adjacent segment health.

Successful outcomes correlate with smoking cessation, healthy weight maintenance, adherence to physiotherapy, and avoidance of heavy manual labour in the early post-fusion period. Bone density optimization with calcium, vitamin D, and (where indicated) anabolic therapy improves fusion in osteoporotic patients.

Cost Factors

Posterolateral spinal fusion costs vary widely by country, number of levels fused, implant type, and hospital setting:

  • United States: $60,000–$150,000+ for single to multi-level PLF including hospital, anaesthesia, surgical fees, and implants. Multi-level or revision cases can exceed $200,000.
  • United Kingdom (private): £20,000–£50,000 for single-level procedures. NHS waiting lists make medical travel attractive for many patients.
  • India (JCI-accredited centres): $5,000–$12,000 for single-level PLF with pedicle screw instrumentation and autograft. Multi-level procedures: $10,000–$20,000.
  • Thailand: $8,000–$18,000 at leading international hospitals such as Bumrungrad or Bangkok Hospital.
  • Turkey: $7,000–$15,000 at accredited spinal surgery centres in Istanbul or Ankara.
  • Key cost drivers: Number of spinal levels fused, instrumentation type (titanium vs. PEEK cages), graft material (autograft vs. BMP), intraoperative neuromonitoring, ICU requirements, rehabilitation programme duration, and implant manufacturer pricing.
  • Insurance: PLF is generally covered when medically indicated with documented failed conservative treatment. Pre-authorization and clinical justification documentation are typically required.

Alternatives to Posterolateral Fusion

  • Conservative management: Physiotherapy, NSAIDs, epidural corticosteroid injections, activity modification, and weight loss should be exhausted before surgery for degenerative conditions. Recommended for at least 6 months in non-emergency cases.
  • Interbody fusion alone (ALIF, PLIF, TLIF, XLIF): Alternative fusion techniques placing structural support within the disc space. Often combined with PLF for maximum stability; used alone in selected cases with excellent disc space preparation.
  • Dynamic stabilization: Devices such as interspinous spacers or dynamic rods aim to offload painful segments without rigid fusion. Long-term evidence is less robust than for fusion, but may be appropriate for carefully selected patients.
  • Artificial disc replacement (total disc arthroplasty): Motion-preserving alternative for single or two-level DDD at L3–S1 in appropriately selected patients. Preserves adjacent segment biomechanics; contraindicated with osteoporosis, significant facet arthritis, or deformity.
  • Decompression alone (laminectomy, discectomy): For patients whose primary problem is nerve compression without significant instability or deformity, decompression without fusion may provide equivalent relief with less surgical morbidity.
  • Radiofrequency ablation (RFA) of facet joints: Minimally invasive denervation of facet joint pain generators; suitable for patients with predominantly facetogenic back pain who are not ideal surgical candidates.

Frequently Asked Questions

Posterolateral fusion (PLF) places bone graft between the transverse processes and facet joints at the back and sides of the spine, accessed through a posterior incision. Interbody fusion (PLIF, TLIF, ALIF, XLIF) places a cage filled with bone graft directly inside the disc space between the vertebral bodies. PLF provides excellent posterolateral column support; interbody fusion restores disc height and provides anterior column support. The two techniques are frequently combined for maximum stability, especially in spondylolisthesis and multi-level disease.
Bony fusion typically begins within 6–8 weeks but is not radiographically mature until 6–12 months post-surgery. CT scanning at 3–6 months is the most reliable method to assess fusion progress. Pedicle screw instrumentation provides immediate mechanical stability while the biological fusion matures, allowing earlier mobilization than historical uninstrumented fusion techniques.
Yes, significantly. Nicotine impairs bone healing by reducing blood supply to the fusion site and inhibiting osteoblast activity. Smokers have 2–3 times higher rates of pseudarthrosis (failed fusion) compared to non-smokers. Most spine surgeons require documented smoking cessation for at least 6–8 weeks before elective PLF and throughout the fusion maturation period. Cessation also reduces anaesthetic and cardiovascular surgical risks.
Adjacent segment disease (ASD) refers to accelerated degeneration at spinal levels immediately above or below a fusion. Fusion changes the biomechanics of the spine, transferring increased load to adjacent segments. Radiographic ASD is seen in approximately 25–45% of patients at 10 years, but symptomatic ASD requiring additional surgery occurs in about 8–15%. It is more common with longer fusion constructs and in older patients with pre-existing adjacent level disease.
Yes. PLF with pedicle screw instrumentation costs $5,000–$12,000 at JCI-accredited hospitals in India and $8,000–$18,000 in Thailand — representing savings of 70–90% versus US pricing. Leading spine centres in India (Apollo, Fortis, Manipal) and Thailand (Bumrungrad, Samitivej) have experienced teams performing hundreds of spinal fusions annually with outcomes data comparable to Western centres. Ensure your chosen centre provides comprehensive pre-operative assessment, intraoperative neuromonitoring, and structured post-surgical physiotherapy.

References

  1. Weinstein JN, et al. Surgical versus nonsurgical therapy for lumbar spinal stenosis. N Engl J Med. 2008;358(8):794–810.
  2. Bridwell KH. Selection of instrumentation and fusion levels for scoliosis. Spine. 2006;31(19 Suppl):S120–S134.
  3. Boden SD, et al. Spine fusion: the gold standard. Eur Spine J. 2002;11(Suppl 2):S97–S103.
  4. Fritzell P, et al. 2001 Volvo Award Winner in Clinical Studies. Lumbar fusion versus nonsurgical treatment for chronic low back pain. Spine. 2001;26(23):2521–2532.
  5. Radcliff KE, et al. Adjacent segment disease after spine surgery: a systematic review and meta-analysis. Clin Orthop Relat Res. 2013;471(7):2150–2166.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-06-26

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.